Fertility and Sterility
Volume 91, Issue 2 , Pages 372-376 , February 2009

Live birth after vitrification of in vitro matured human oocytes

  • Ri-Cheng Chian, Ph.D.

      Affiliations

    • McGill Reproductive Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    • ,
  • Lucy Gilbert, M.D.

      Affiliations

    • Division of Gynecological Oncology, McGill University, Montreal, Quebec, Canada
    • ,
  • Jack Y.J. Huang, M.D.

      Affiliations

    • McGill Reproductive Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    • ,
  • Ezgi Demirtas, M.D.

      Affiliations

    • McGill Reproductive Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    • ,
  • Hananel Holzer, M.D.

      Affiliations

    • McGill Reproductive Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    • ,
  • Alice Benjamin, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada
    • ,
  • William M. Buckett, M.D.

      Affiliations

    • McGill Reproductive Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    • ,
  • Togas Tulandi, M.D., M.H.C.M.

      Affiliations

    • McGill Reproductive Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    • ,
  • Seang Lin Tan, M.D., M.B.A.

      Affiliations

    • McGill Reproductive Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Seang Lin Tan, M.D., M.B.A., Women's Pavilion F3, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec, Canada H3A 1A1 (FAX: (514) 843-1678).

Received 28 October 2007 ,Revised 28 November 2007 ,Accepted 28 November 2007.

References 

  1. American Cancer Society . Cancer facts and figures 2006. Atlanta, GA: American Cancer Society; 2006;
  2. Bleyer W. The impact of childhood cancer on the United States and the world. CA Cancer J Clin. 1990;40:355–367
  3. Ries L, Percy C, Bunin G. Introduction. In:  Gurney J,  Linet M,  Tamra T,  Young J,  Bunin G editor. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995 (NIH Pub No 99-4649). Bethesda, MD: National Cancer Institute; 1999;p. 1–15
  4. Rao GD, Chian RC, Son WS, Gilbert L, Tan SL. Fertility preservation in women undergoing cancer treatment. Lancet. 2004;363:1829–1830
  5. Huang JY, Buckett WM, Gilbert L, Tan SL, Chian RC. Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol. 2007;105:542–544
  6. Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. Published online June 1, 2007.
  7. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–2931
  8. Ethics Committee of the American Society of Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622–1628
  9. Practice Committee of the American Society of Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2004;82:993–998
  10. Kuleshova LL, Lopata A. Vitrification can be more favorable than slow cooling. Fertil Steril. 2002;78:449–454
  11. Katayama KP, Stehlik J, Kuwayama M, Kato O, Stehlik E. High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril. 2003;80:223–224
  12. Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online. 2005;11:300–308
  13. Chian RC, Son WY, Huang JYJ, Cui SJ, Buckett WM, Tan SL. High survival rates and pregnancies of human oocytes following vitrification: preliminary report. Fertil Steril. 2005;84:S36
  14. Lucena E, Bernal DP, Lucena C, Rojas A, Moran A, Lucena A. Successful ongoing pregnancies after vitrification of oocytes. Fertil Steril. 2006;85:108–111
  15. Tan SL, Child TJ, Gulekli B. In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography. Am J Obstet Gynecol. 2002;186:684–689
  16. Chian RC, Gulekli B, Buckett WM, Tan SL. Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med. 1999;341:1624–1626
  17. Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod. 2000;15:165–170
  18. Chian RC, Buckett WM, Tan SL. In-vitro maturation of human oocytes. Reprod Biomed Online. 2004;8:148–166
  19. Chian RC, Lim JH, Tan SL. State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol. 2004;16:211–219
  20. Le Du A, Kadoch IJ, Bourcigaux N, Doumerc S, Bourrier MC, Chevalier N, et al. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod. 2005;20:420–424
  21. Jurema MW, Nogueira D. In vitro maturation of human oocytes for assisted reproduction. Fertil Steril. 2006;86:1277–1291
  22. Son WY, Chung JT, Dean N, Lukic J, Holzer HE, Chian RC, et al. Comparison of fertilization and embryonic development in sibling mature oocytes retrieved from different follicle sizes on retrieval in IVM cycles. Hum Reprod. 2007;22:i109
  23. Centers for Disease Control and Prevention. 2003 Assisted Reproductive Technology (ART) Report: Section 2-ART Cycles Using Fresh, Nondonor Eggs or Embryos. Available at: http://wwwcdcgov/art/art2003/sect2_fig3-13htm#Figure%203. Accessed on October 20, 2007.
  24. Andersen AN, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG. Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Hum Reprod. 2006;21:1680–1697
  25. Gunby J, Daya S. Assisted reproductive technologies (ART) in Canada: 2003 results from the Canadian ART Register. Fertil Steril. 2007;88:550–559
  26. Buckett WM, Chian RC, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol. 2007;110:885–891
  27. Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol. 1995;102:767–772
  28. Tan SL, Maconochie N, Doyle P, Campbell S, Balen A, Bekir J, et al. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol. 1994;171:513–520
  29. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet. 1999;354:1586–1590
  30. Venn A, Jones P, Quinn M, Healy D. Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients. Gynecol Oncol. 2001;82:64–68

 Funded by grants received by Ri-Cheng Chian from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) and by departmental research funds.

PII: S0015-0282(07)04153-2

doi: 10.1016/j.fertnstert.2007.11.088

Fertility and Sterility
Volume 91, Issue 2 , Pages 372-376 , February 2009

Article Tools

* Image Usage & Resolution